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Abstract: Early investigations of the neuroticism by conscientiousness interaction with regards to health
have been promising, but to date, there have been no systematic investigations of this interaction that
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The current study - the second of three - uses a coordinated analysis approach to test the impact of the
neuroticism by conscientiousness interaction on the prevalence and incidence of chronic conditions. Using
15 pre-existing longitudinal studies (N > 49,375), we found that conscientiousness did not moderate the
relationship between neuroticism and having hypertension (OR = 1.00,95%CI[0.98,1.02]), diabetes (OR
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0.98,[0.95,1.01]), diabetes (OR = 0.99[0.94,1.05]), or heart disease (OR = 0.98[0.94,1.03]). Heterogeneity
of effect sizes was largely nonsignificant, with one exception, indicating that the effects are consistent
between datasets. Overall, we conclude that there is no evidence that healthy neuroticism, operationalized
as the conscientiousness by neuroticism interaction, buffers against chronic conditions.
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Early investigations of the neuroticism by conscientiousness interaction with regards to health have been 
promising, but to date, there have been no systematic investigations of this interaction that account 
for the various personality measurement instruments, varying populations, or aspects of health. The 
current study – the second of three – uses a coordinated analysis approach to test the impact of the 
neuroticism by conscientiousness interaction on the prevalence and incidence of chronic conditions. Using 
15 pre-existing longitudinal studies (N > 49,375), we found that conscientiousness did not moderate the 
relationship between neuroticism and having hypertension (OR = 1.00,95%CI [0.98,1.02]), diabetes (OR 
= 1.02[0.99,1.04]), or heart disease (OR = 0.99[0.97,1.01]). Similarly, we found that conscientiousness 
did not moderate the prospective relationship between neuroticism and onset of hypertension (OR = 
0.98[0.95,1.01]), diabetes (OR = 0.99[0.94,1.05]), or heart disease (OR = 0.98[0.94,1.03]). Heterogeneity 
of effect sizes was largely nonsignificant, with one exception, indicating that the effects are consistent 
between datasets. Overall, we conclude that there is no evidence that healthy neuroticism, operationalized 
as the conscientiousness by neuroticism interaction, buffers against chronic conditions.
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Defined by heightened negative affect and emotional 
instability, the personality trait neuroticism is associated 
with nearly all aspects of poor health, from daily health 
behaviors such as smoking (Hakulinen et al., 2015) 
and alcohol consumption (Luchetti et al., 2018), to the 
increased risk of developing chronic conditions (Jokela 
et al., 2014; Weston et al., 2015), to greater symptomatic 
complaints (Costa Jr. & McCrae, 1987), and to mortality 
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(Graham et al., 2017). Findings such as these have led 
some to regard neuroticism to be a public health concern 
(Lahey, 2009). Yet, this characterization of neuroticism 
is premature because the literature examining the 
neuroticism-health relationship is quite mixed. While 
many studies find neuroticism associated with poor 
health, other studies find no association between these 
constructs (e.g., Friedman, Kern, & Reynolds, 2010; Jokela 
et al., 2013). Still others find that neuroticism is linked to 
better health, most notably greater longevity (Brickman, 
Yount, Blaney, Rothberg, & De-Nour, 1996; Ragland & 
Brand, 1988).
One possible explanation for conflicting findings is 
that neuroticism may influence health through multiple 
pathways (Friedman, 2000). If this is true, the heterogeneity 
of findings represents truly different and conflicting 
mechanisms through which neuroticism both improves 
and weakens health. Hypothetical pathways connecting 
neuroticism to negative health outcomes include taking 
part in unhealthy behaviors, avoiding medical care, and 
experiencing poorer outcomes. In contrast, there may 
be pathways connecting neuroticism to positive health 
outcomes through vigilance towards changes in health, as 
well as seeking out and complying with medical advice. It 
is unclear whether a person high in neuroticism can take 
multiple pathways simultaneously or switch from one 
pathway to another during the course of their life or are 
confined to the path they first walk down. These different 
possibilities would indicate different types of predictors: 
situational, developmental/life-stage relevant, or stable, 
respectively.
To date, one promising candidate predictor is the 
personality trait of conscientiousness. The notion that 
another personality trait shapes the path of a person 
high in neuroticism is consistent with early descriptions 
of “healthy neuroticism” (Friedman, 2000), which divided 
people into types: unhealthy and healthy neurotics 
(pp. 1102). Based solely on description, conscientiousness 
does appear to be a likely predictor of healthy neurotic 
behavior. Conscientious individuals avoid unhealthy 
behaviors (Bogg & Roberts, 2004) and adhere to 
medication properly (Hill & Roberts, 2011; O’Cleirigh, 
Ironson, Weiss, & Costa Jr., 2007). Indeed, the confluence 
of high conscientiousness and high neuroticism, which 
some have defined as being “overcontrolled” (Costa Jr. & 
McCrae, 1998), has been shown to be associated with lower 
rates of smoking (Terracciano & Costa Jr., 2004; Vollrath 
& Torgersen, 2002), alcohol use (Turiano, Whiteman, 
Hampson, Roberts, & Mroczek, 2012), and inflammation 
(Turiano, Mroczek, Moynihan, & Chapman, 2013).
That being said, this combination of traits is not 
consistently associated with better health. For example, 
the combination of high conscientiousness and high 
neuroticism does not reliably predict smoking (e.g., Turiano 
et al., 2012) or may only do so for certain populations, 
such as those diagnosed with chronic conditions (Weston 
& Jackson, 2015). Finally, given the propensity for null 
results to go unpublished (Bakker, Dijk, & Wicherts, 
2012; Franco, Malhorta, & Simonovits, 2014), it is difficult 
to determine how many times the combination of 
neuroticism and conscientiousness has been tested and 
resulted in non-significance. Thus, it is possible that the 
interaction between neuroticism and conscientiousness is 
unrelated to health and appears in the literature merely 
through sampling error or publication bias.
The current study is the second in a series of three studies 
investigating how neuroticism, conscientiousness, and 
their interaction are associated with health outcomes and 
mortality. The first study in this series examines these traits 
in relation to health behaviors (i.e., smoking, drinking, 
and physical activity; Graham et al., this issue); the current 
and second study examines chronic conditions; and the 
third study examines mortality (Turiano et al., this issue).
Chronic Conditions
There is evidence that personality is associated with 
chronic condition status. Decreasing optimism is generally 
linked with greater likelihood of developing a health 
condition (e.g. stroke, diabetes, hypertension; Chopik, 
Kim, & Smith, 2015), and neuroticism is prospectively 
linked to the development of hypertension and heart 
disease (Weston et al., 2015). Conscientiousness, on the 
other hand, has been found to be generally protective. 
For example, conscientiousness is associated with lower 
rates of hypertension and diabetes (Goodwin & Friedman, 
2006; Weston et al., 2015). We build upon this work by 
addressing whether the combination of high neuroticism 
and high conscientiousness offsets the risk of developing 
health conditions.
To narrow the scope of this study, we chose to examine 
chronic conditions that are both widely prevalent and 
heavily influenced by behavior. These were hypertension, 
diabetes, and cardiovascular disease, which are among the 
10 most prevalent chronic conditions in American adults, 
with hypertension being the most prevalent (Gerteis et 
al., 2015). Further, cardiovascular disease is ranked the 
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number one leading cause of death worldwide (National 
Center for Health Statistics, 2017) and was estimated to 
cost Americans more than $300 billion in 2012–2013 
(Benjamin et al., 2017). During the same period, diabetes 
was estimated to cost more than $245 billion (American 
Diabetes Association, 2013). These chronic conditions 
represent some of the most severe costs to Westernized 
societies, both physically and financially. Moreover, each 
is linked to smoking, diet, and physical activity (Wingard, 
Berkman, & Brand, 1982), the health behaviors we 
investigated in the first project of this series.
Coordinated Analysis
Coordinated analysis, a form of integrative data analysis 
(Curran & Hussong, 2009), involves the direct comparison 
of results based on independent analysis of multiple 
data sets (Hofer & Piccinin, 2009, 2010). This method is 
sometimes referred to as a two-step individual participant 
data meta-analysis (Hakulinen et al., 2015; Riley, Lambert, 
& Abo-Zaid, 2010). Coordinated analyses strengthen the 
interpretation of results in several ways. By combining the 
individual results from multiple samples, the statistical 
power to detect the effect is greatly increased. Differences 
in key study characteristics (e.g., measurement of 
variables, the historical era in which the study took place, 
the age range and other characteristics of the samples, the 
number and timing of measurement occasions, the types 
of sampling procedure used, etc.) can provide a challenge 
to researchers who seek to understand similarities and 
differences among results from these samples. One 
solution is to harmonize variables across studies – for 
example, by creating binary variables that represent the 
absence and presence of a given condition – to reduce 
between-study differences. However, coordinating at the 
lowest possible denominator limits the quality of data 
available within studies, and may not be suitable for 
some variables. Further, too much harmonization on the 
variable level may severely limit the generalizability or 
even the interpretability of results.
Another solution is to harmonize models rather than 
measures (Hofer & Piccinin, 2009, 2010). To do so, identical 
(or nearly identical) statistical models are built using 
conceptually similar, rather than identically measured, 
constructs. Harmonizing at the level of the model is 
one of the strengths of coordinated analysis of existing 
longitudinal data. Specifically, researchers can examine 
the heterogeneity of studies not as error but as potential 
sources of variability. For example, systematic differences 
between studies collected during different historical 
eras are evidence of cohort effects. However, it must be 
acknowledged that including additional variables means 
adding researcher degrees of freedom (John, Loewenstein, 
& Prelec, 2012; Simmons, Nelson, & Simonsohn, 2011). 
Thus, it is imperative that studies that use coordinated 
analysis pre-register their analytic plans, so as to delineate 
their planned and exploratory comparisons.
The current study used coordinated analysis to 
examine the interaction between neuroticism and 
conscientiousness and its relationship to the diagnosis 
of three major chronic conditions. We ask two main 
research questions. First, to what extent is the interaction 
between neuroticism and conscientiousness concurrently 
associated with having been diagnosed with hypertension, 
diabetes and heart disease. Second, to what extent is the 
interaction between neuroticism and conscientiousness 
prospectively associated with the development of 
hypertension, diabetes and heart disease. By using 
coordinated analysis, we can estimate these relationships 
first within individual studies and then across all studies. 
These analyses allow us to estimate a population-level 
effect size (with the population limited to the cultures and 
countries in which these data were collected), as well as 
the potential heterogeneity of each effect.
The current study is the second in a series of three studies 
submitted together. These studies were the result of a 
single, coordinated project involving multiple co-principal 
investigators and research labs around the world. The goal 
of this project was to rigorously analyze the evidence for 
“healthy neuroticism,” narrowly defined as the significant 
moderation of the neuroticism-health relationship by 
conscientiousness. This analysis considered multiple 
components of health, specifically behaviors, development 
of (chronic) conditions, and mortality, following a lifespan 
trajectory. Despite the coordination and similarity of 
analyses among these three components of health, there 
were notable differences between the studies, including 
the datasets which could be used in the analysis, the 
quantitative models applied, and the theoretical rationale 
linking personality to health. Moreover, synthesizing this 
project in a single manuscript would have required over-
simplification of critical details and decision points along 
the way. As a result, the three components were divided 
into three separate but linked manuscripts, allowing for 
the requisite detail to be included in each.
Methods
Supplemental material
Raw data could not be made public, due to data sharing 
agreements by the organizations that collected the data. 
Results of within-study analyses and meta-analyses are 
available at osf.io/48fhe. Supplemental files – including 
R code, additional analyses, and more detailed study 
information – can be found at IALSAging.github.io/
HealthyN.
Studies and Participants
Study information and descriptive statistics can be found 
in Table 1.
The Berlin Aging Study II (BASE-II) consists of a 
subsample of younger (20–35 years of age) and older 
adults (60–84 years of age) who were recruited from the 
greater metropolitan area of Berlin (for an overview, see 
Bertram et al., 2013; Gerstorf et al., 2016). Starting in 
2009, a total of 1,437 (M
age
 = 60.16, SD
age
 = 15.77, 50% 
female) participants were eligible for the current analyses.
The Einstein Aging Study (EAS) is an observational 
longitudinal cohort study of cognitive aging and 
dementia, which began in 1993. Older adults who were 
at least 70 years of age, non-institutionalized, and native 
English speakers were systematically recruited from an 
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urban, multi-ethnic, community-dwelling population 
in Bronx County, New York, USA. Participants receive 
comprehensive annual medical and neuropsychological 
evaluations (Katz et al., 2012). A total of 734 (M
age
 = 78.83, 
SD
age
 = 5.31, 61% female) participants were eligible for the 
current analyses.
The English Longitudinal Study of Ageing (ELSA) is a 
longitudinal cohort survey that collects multidisciplinary 
information on older adults living in England. Data 
collection began in 2002, and new participants were 
added at waves 3, 4, 6 and 7 to maintain size and 
representativeness (Marmot et al., 2017). A total of 6,263 
(M
age
 = 66.39, SD
age
 = 8.55, 56% female) participants were 
eligible for the current analyses.
The Health and Retirement Study (HRS) is a 
longitudinal panel that tracks retirement-age adults in 
the United States. Data collection began in 1992, with 
new cohorts added throughout the 1990s (Sonnega et al., 
2014). A total of 18,925 (M
age
 = 66.28, SD
age
 = 11.14, 58% 
female) participants were eligible for the current analyses.
The Interdisciplinary Longitudinal Study of Adult 
Development and Aging (ILSE) is a multidisciplinary 
longitudinal study investigating the aging process of 
two German birth cohorts born between 1930–1932 
and 1950–1952 (see Sattler et al., 2015 for an overview). 
For the current analysis, only individuals from the older 
cohort born between 1930–1932 were included (e.g., 
Aschwanden, Kliegel, & Allemand, 2018). Data collection 





 = 0.96, 52% female) were eligible for the 
current analyses.
The Lothian Birth Cohort 1936 (LBC1936) consists 
of individuals who were born in 1936 and completed the 
Scottish Mental Survey in 1947 (Deary, Gow, Pattie, & Starr, 
2012; Taylor, Pattie, & Deary, 2018). The LBC1936 cohort 
was recruited between 2004 and 2007 by identifying 
individuals from the original cohort who were residing 
in Edinburgh and the surrounding areas. In total, 1,091 
participants entered the study. A total of 959 participants 
were eligible for the current analyses (M
age




The Long Beach Longitudinal Study (LBLS) started 
in 1978 and was made up of 28–84 year old participants 
from southern California. This sample was reassessed in 
1994–1995, and has since been assessed two additional 
times (2000–2002 and 2008–2013). Additional cohorts 
were added in the second two waves of data collections 
(Zelinski & Kennison, 2001). A total of 935 participants 
were eligible for the current analyses (M
age




The Memory and Aging Project (MAP) is a longitudinal, 
epidemiologic clinical-pathologic cohort study of common 
chronic conditions of aging with emphasis on decline 
in cognitive and motor function and risk of Alzheimer’s 
disease (Bennett et al., 2018; Bennett, Schneider, et 
al., 2012). Participants are older adults recruited from 
retirement communities and subsidized senior housing 
facilities throughout the Chicago metropolitan area and 
northeastern Illinois. Participants do not have known 





 = 7.14, 76% female) were eligible for the 
current analyses.
The Midlife in the United States Study (MIDUS) 
is an ongoing nationally representative study of 7,108 
participants in the United States recruited in 1994/1995. 
Since then, it has added two waves of data collection, 
Table 1: Descriptive Statistics.














BASE-II Germany 1,437 2009 21–84 BFI-S 4.17 (5) 7% (4%) 36% (15%) 10% (6%)
EAS U.S. 734 2005 69–99 IPIP-50 3.94 (11) 19% (17%) 66% (22%) 37% (15%)
ELSA U.K. 6263 2002 29–99 MIDI 3.89 (5) 8% (4%) 39% (11%) 18% (8%)
HRS U.S. 18,925 2006 25–105 MIDI 5.19 (9) 20% (8%) 55% (23%) 22% (12%)
ILSE Germany 478 1994 60–64 NEO-FFI 11.37 (13) 11% (4%) 42% (14%) 41% (32%)
LBC1936 U.K. 959 2006 67–71 IPIP 6.53 (12) 8% (7%) 40% (12%) 24% (13%)
LBLS U.S. 935 1994 30–97 NEO-PI-R 9.00 (9) 10% (58%) 46% (51%)
MAP U.S. 604 1997 56–97 NEO-FFI 8.41 (14) 14% (10%) 54% (30%) 10% (8%)
MAS Australia 860 2005 70–91 NEO-PI-R 5.81 (9) 12% (4%) 61% (35%) 35% (13%)
MIDUS U.S. 5,988 1994 20–75 MIDI 11.54 (19) 5% (12%) 14% (52%) 11% (11%)
NAS U.S. 820 1990 47–85 Goldberg 14.10 (26) 11% (5%) 41% (18%) 23% (13%)
OATS Australia 463 1997 65–90 NEO-PI-R 3.74 (9) 10% (3%) 52% (17%) 25% (7%)
ROS U.S. 1,326 1994 55–103 NEO-FFI 9.10 (23) 13% (11%) 45% (37%) 10% (7%)
SLS U.S. 876 2001 29–100 NEO-PI-R 6.98 (7) 18% 46% (30%) 72%
WLS U.S. 10,560 1993 33–75 BFI 18.00 (18) 4% (13%) 23% (46%) 7% (19%)
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one in 2004/2005 and one in 2013/2014 (Brim, Ryff, & 
Kessler, 2004). A total of 5,988 participants were eligible 
for the current analyses (Mage = 46.85, SD
age
 = 12.91, 52% 
female).
The Veterans Affairs Normative Aging Study (NAS) is 
a study of the medical and psychosocial aging among men 
in the United States and is funded by the United States 
Department of Veterans Affairs (Bossé, Ekerdt, & Silbert, 
1984). The sample was originally based in the Greater 
Boston, Massachusetts metropolitan area and consisted of 
2,280 men enrolled from 1961 to 1970. The participants 
were on average 42 years old at enrollment. A total of 820 






The Older Australian Twins Study (OATS) is a multi-
site longitudinal study of monozygotic and dizygotic 
twins aged at least 65 years, with a cohort of 623 
participants assessed at baseline, and is the largest, most 
comprehensive study of older twins in Australia (Sachdev 
et al., 2009). At present, three waves, each spaced two 
years apart, have been completed, although due to cohort 
attrition, only 391 participants from the initial cohort 
have completed the third wave. A total of 463 participants 
(M
age
 = 71.28, SD
age
 = 5.37, 66% female) were eligible for 
the current analyses.
The Religious Orders Study (ROS) is a longitudinal, 
epidemiologic clinical-pathologic cohort study of aging 
and Alzheimer’s disease that enrolls older Catholic nuns, 
priests, and brothers from more than 40 groups across 
the United States (Bennett et al., 2018, 2012). Participants 
do not have known dementia at baseline. A total of 1,326 
(M
age
 = 75.94, SD
age
 = 7.43, 71% female) participants were 
eligible for the current analyses.
The Sydney Memory and Ageing Study (MAS) is an 
ongoing longitudinal cohort study of brain aging and 
dementia in older individuals, who undertake medical, 
neuropsychological and psychosocial assessments 
approximately every two years. Individuals aged 70–90 
and living in the Australian community at baseline were 
randomly recruited through the electoral roll (Sachdev 
et al., 2010). The baseline MAS cohort comprised 1,037 
individuals without dementia, of whom 860 were eligible 
for the current analyses (M
age
 = 78.66, SD
age
 = 4.76, 46% 
female).
The Seattle Longitudinal Study (SLS) started in 1956 
and has since collected data on close to 6,000 participants 
in a cohort-sequential design (Schaie, Willis, & Caskie, 
2004). Participants were sampled randomly from members 
of a large health maintenance organization in the Seattle, 
Washington area. A total of 876 participants (M
age
 = 68.27, 
SD
age
 = 13.63, 56% female) were eligible for these analyses.
The Wisconsin Longitudinal Study (WLS) follows a 
cohort of men and women who graduated from Wisconsin 
high schools in 1957. Data from graduate participants 
(N = 10,317) span almost 60 years from the baseline 
assessment in 1957, with follow-up assessments collected 
up to five times, ending in 2011 (Herd, Carr, & Roan, 2014). 
In addition to the original cohort, subsequent assessments 
included randomly selected siblings and spouses of 





 = 4.45, 54% female) were eligible for these 
analyses.
Measures
Collectively, the measures of personality traits used 
covered a wide range of narrow constructs that are 
typically assessed by the broader Big Five model. It is worth 
noting some systematic differences between the scales. 
For example, the IPIP-50 measure of conscientiousness 
included items assessing responsibility, practicality, and 
thriftiness but not self-discipline or efficiency; in contrast, 
the BFI measures competency and achievement but not 
goal-striving. To some extent, these difference in trait 
coverage across scales is an asset to these analyses: a lack 
of significant differences in effects would suggest that 
estimated relationships are robust to choice of scale, while 
significant differences may point to specific mechanisms 
(i.e., narrower traits) which may underlie and inspire 
investigation of causal mechanisms. We provide a table 
of content measurement by scale online on the page 
Personality Scale Content and invite comparisons across 
these measures.
The details of each measure, including item text are 
described online (Study Information), and descriptive 
statistics for each variable used are also available online 
(Descriptive Statistics). Supplementary files are available 
at IALSAging.github.io/HealthyN.
Personality
Personality traits were assessed using various measures 
of the Big Five (i.e., neuroticism, conscientiousness, 
extraversion, agreeableness, and openness to experience). 
Different measures of the same trait are highly correlated 
(Luteijn, Starren, & Van Dijk, 2000; McCrae & Costa Jr., 
1985), which allows for a comparison of the effects of 
the same construct across studies. All but two of the data 
sets had measures of all five personality traits. The MAP 
study had measures of neuroticism, conscientiousness 
and extraversion, and the MAS had neuroticism, 
conscientiousness and openness. The most commonly 
used measures were from the NEO family of instruments 
(Costa Jr. & McCrae, 2008). The NEO-PI-R was used in the 
LBLS, OATS and MAS, and the NEO-FFI (Costa Jr. & McCrae, 
1989) was used in the ILSE, ROS, and MAP.
Other measures included the Big Five Inventory (John & 
Srivastava, 1999), used in the BASE-II and WLS; the Midlife 
Developmental Inventory Personality Scale (Lachman 
& Weaver, 1997), a short adjective scale developed for 
panel studies, used in the HRS, MIDUS and ELSA; the 
IPIP-50 (Goldberg et al., 2006), used in the EAS and the 
LBC 1936; and Goldberg’s (1992) 50 adjectives, used 
in the NAS. Cronbach’s alpha was calculated from the 
samples of participants who were eligible for analyses. 
Internal reliability estimates for neuroticism ranged from 
0.66 (BASEII) to 0.93 (SLS). Internal reliability estimates 
for conscientiousness ranged from 0.56 (MIDUS) to 0.91 
(NAS). When available, the other personality traits were 
included as covariates in the models; reliability estimates 
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for the personality covariates are included online 
(Descriptive Statistics).
Chronic Condition Status
In 12 of the 15 studies, participants were asked, “Have 
you ever been diagnosed with” or “has a doctor or nurse 
ever told you that you have” for each of several chronic 
conditions. Their answers were coded 1 for yes and 0 for no. 
This method was used to represent hypertension, diabetes 
and heart disease in BASE-II, ELSA, HRS, LBC, MIDUS, NAS, 
ROS, MAP, EAS, OATS, MAS, LBLS and WLS. Some studies 
asked about hypertension only (BASE-II, EAS, ILSE, NAS), 
others asked about hypertension or high blood pressure 
(ELSA, HRS), and others only asked about high blood 
pressure (LBLS, ROS, MAP, OATS, MAS). Only the protocols 
in the EAS distinguished between Type I and Type II 
diabetes. For heart condition, we included any condition 
related to cardiovascular health. For specific conditions 
listed in each study, see the online supplemental (Study 
Information). Finally, ILSE protocols included listening to 
heart sounds as part of a medical checkup conducted by 
one to two trained study geriatricians. For all studies, we 
simplified coding to 0 (not diagnosed with condition) and 
1 (diagnosed with condition).
Covariates
Models were adjusted for the following covariates: 
age, sex, education, body mass index, other chronic 
conditions, extraversion, agreeableness and openness to 
experience. Age in all studies was age at first personality 
assessment (i.e., baseline age), standardized within study 
by subtracting the study’s mean age and dividing by its 
standard deviation. We included average study age as a 
between-study variable when examining heterogeneity 
between studies. Sex was coded as 0 for male and 1 for 
female. Education in BASE-II, EAS, HRS, LBLS, LBC, ROS, 
OATS, MAS, and MAP was measured as the number of 
years of education. In ELSA, ILSE, MIDUS, NAS, and WLS, 
education was measured using an ordinal scale that 
referred to the highest degree earned; for the purposes 
of harmonization, we treated these as interval variables. 
We standardized education within study by subtracting 
the study’s mean education value and dividing by its 
standard deviation. Body mass index (BMI) was measured 
as kg/m2 or lb/in2 × 702. Height and weight were self-
reported in BASE-II, HRS, LBLS, LBC, MIDUS, and WLS 
while researchers or medical professionals measured 
height and weight in ELSA, ILSE, NAS, ROS, EAS, OATS, 
MAS, and MAP. Again, BMI was standardized within study. 
Other chronic conditions indicated whether a person had 
(1) or had not (0) been diagnosed with any of the other 
chronic conditions assessed by the study. Personality traits 
other than neuroticism and conscientiousness that were 
measured were also included as covariates.
Between-study variables
Diabetes assessment indicated whether a measure 
distinguished between Type I and Type II diabetes (0) or 
specifically measured only Type II diabetes (1; the latter 
included the ELSA, the NAS, the MAS, the OATS, the LBLS 
and the prospective measurement in the WLS). Mean study 
age was the average age of participants in the study, prior 
to standardization. Average study length and maximum 
study length were measures of the amount of time 
between baseline assessment and final chronic condition 
assessment. The average study length ranged from 3.74 
years (OATS) to 18.00 years (WLS) and the maximum study 
length elapsed ranged from 5 years (BASEII and ELSA) to 
26 years (NAS).
Data analysis
We used R (Version 3.6.2; R Core Team, 2018) for our 
meta-analyses and visualization. The inferential models 
were run on each study’s data using binary logistic 
regression. Functions in the metafor package (Version 
2.0.0; Viechtbauer, 2010) were used to estimate the 
overall effects and heterogeneity between studies, as well 
as to create forest plots. The sjPlot package (Version 2.5.0; 
Lüdecke, 2018) was used to calculate predicted values 
for each study and the ggplot2 package (Version 3.0.0; 
Wickham, 2016) was used to visualize effects. Additional 
package information, including the version used for each 
individual study analysis, is provided online (R Packages 
Used).
Individual Study Analysis
We ran the same inferential models within each dataset. 
First, the presence of hypertension, diabetes and a 
heart condition were each separately regressed onto 
neuroticism, conscientiousness, and their interaction, 
using data from each participant’s first personality 
assessment occasion. These models controlled for age, 
sex, education, the other personality traits in the study, 
BMI, and whether the participant had been diagnosed 
with another chronic condition. Second, the presence of 
hypertension, diabetes, and a heart condition at the last 
study wave to date for each individual were each separately 
regressed onto baseline neuroticism, conscientiousness, 
and their interaction, excluding participants diagnosed 
with the outcome at baseline. In other words, the models 
examine the association between personality and the 
prospective development (i.e., incidence) of the chronic 
condition. All predictors and covariates were measured at 
baseline (i.e., the first time the participant had completed 
the personality assessment).
Meta-analyses
The analytic tools of meta-analysis were used to estimate 
the average weighted effect size of the interaction 
of neuroticism and conscientiousness in each of the 
models described above. As part of this estimation, 
we calculated the heterogeneity between the studies. 
Finally, we examined the role of three between-study 
variables in explaining any variability in the effect. 
Those variables were the personality scale, the method 
of assessing chronic condition status, and, in the case of 
diabetes as an outcome, whether the study included Type 
I diabetes in their assessment. When examining variation 
in the association of personality with the prospective 
development of chronic conditions, we also examined the 
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average number of years between personality assessment 
and the most recent assessment, as well as the maximum 
number of years.
All models used listwise deletion. Sample sizes for each 
model in each dataset are presented in the relevant figure 
or table.
Power analysis (post-hoc)
Given the anticipated sample size, we did not believe 
a power analysis was necessary with regards to our 
interaction coefficient estimate, or the coefficient 
estimates of neuroticism and conscientiousness. However, 
our power to detect significant heterogeneity in effect 
sizes between studies is unclear. We estimate our power 
using methods described by Hedges and Pigott (2004). 
Based on the within-study variability and number of 
studies, we estimate that we are sufficiently able (power 
> .90) to detect heterogeneity of at least a standard 
deviation (in odds ratios) of .06 (corresponding τ of .10). 
We note that the majority of psychological meta-analyses 
find between study variability between tau of 0 and .25 
(Van Erp, Verhagen, Grasman, & Wagenmakers, 2017). See 
our online page, Power Analysis (https://ialsaging.github.
io/healthyn/chronic_power_analysis.html), for more 
information about our power analysis.
Preregistered analyses
This study was preregistered on OSF (osf.io/m7aen). 
While data had been collected prior to analysis, the 
current study constitutes a preregistration because the 
analytic decisions were made by the first author prior to 
examination of most of the data. Moreover, the first author 
only analyzed a subset of one of the fifteen data sets (i.e., 
the HRS) for the explicit purpose of ensuring the scripts 
would run smoothly prior to registering the analytic plan 
and sharing analytic scripts with the other data analysts. 
The process for analyzing the data was as follows:
The first author decided which chronic conditions to use 
as outcomes and which variables to use as covariates. The 
first author wrote code to evaluate the inferential models 
in R. This R script created an output object containing 
meta-data, descriptive statistics, statistics from the 
inferential models, and values predicted from the model. 
The output object could not contain raw data, as many 
of the datasets used here are not available in the public 
domain. As a consequence, we are unable to post the raw 
data, but we have posted the output objects of each study. 
To test and refine this script, the first author, who had 
analyzed the HRS data in prior publications, then cleaned 
the HRS data and created multiple pseudo-versions of the 
HRS by randomly sampling rows with replacement. The 
inferential analysis script was run on each of these pseudo-
HRS samples to create pseudo-output objects. Finally, 
“meta-analysis” scripts were written to extract relevant 
information from each of the output objects and evaluate 
the overall effect from the individual analyses. These 
scripts were tested on the pseudo-output generated when 
testing the inferential models. At this point, the study was 
pre-registered and included a template inferential analysis 
script to be adapted for each individual data set and several 
meta-analysis scripts that could evaluate the output of the 
models on the individual data sets. After pre-registration, 
individual data analysts downloaded the R script and ran 
this on their respective data set. Output objects were 
created and uploaded to OSF; the first author then used 
the meta-analysis scripts on these output objects.
Deviations
It was unknown at the time of preregistration that many 
studies did not have a measure of self-rated health, which 
was a preregistered covariate. Therefore, the analyses 
presented here do not include self-rated health as a 
covariate. However, for data sets that did include this 
variable, analyses that included self-rated health were 
also conducted, and the results from those analyses 
are available at osf.io/48fhe. Additional exploratory 
analyses, decided upon during the data analysis phase, 
were models that examined the three-way interaction 
of neuroticism, conscientiousness and age. These are 
mentioned briefly in the Results section and are labelled 
as exploratory. All exploratory analyses controlled for 
age, sex, education, the other personality traits, BMI, and 
whether the participant had been diagnosed with another 
chronic condition. Finally, although we registered that 
we would examine personality measures as a moderator 
of results, we did not specify how those scales would be 
coded. We were unable to preregister this result because 
at the time of pre-registration, the data analyst did not 
have the information necessary to decide how to code the 
scales. Full information regarding the participant sample, 
recruitment and survey procedures, and the measures 
used is available in Supplementary File 1 (osf.io/vwfjr), 
and the data necessary for testing the meta-study models 
are available on OSF (osf.io/48fhe); we invite, interested 
readers to recode these data in whatever way they believe 




Consistent with prior research, the meta-analytic 
effects showed that greater odds of hypertension were 
concurrently associated with higher levels of neuroticism 
(OR = 1.07, 95% CI = [1.02, 1.13]) and lower levels of 
conscientiousness (OR = 0.93, 95% CI = [0.89, 0.98]). The 
hypertension-neuroticism effect was only significant in 
three studies: the HRS (OR = 1.05, 95% CI [1.02, 1.08]), 
the LBLS (OR = 1.20, 95% CI [1.05, 1.38]), and the WLS 
(OR = 1.28, 95% CI [1.22, 1.34]). The hypertension-
conscientiousness link was only significant in the ELSA 
(OR = 0.81, 95% CI [0.76, 0.85]), the HRS (OR=0.83, 95% 
CI [0.81, 0.86]), and the MIDUS (OR = 0.92, 95% CI [0.86, 
1.00]).
The meta-analytic effects indicated that neuroticism 
was prospectively associated with hypertension (OR = 
1.05, 95% CI = [1.02, 1.08]), but conscientiousness was 
not (OR = 0.97, 95% CI = [0.91, 1.02]). In the individual 
study analyses, the prospective hypertension-neuroticism 
association was only significant in the HRS (OR = 1.06, 
95% CI [1.00, 1.11]) and the WLS (OR = 1.06, 95% CI [1.01, 
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1.11]). The prospective hypertension-conscientiousness 
association was only significant in the ELSA (OR = 0.85, 
95% CI [0.76, 0.94]) and the HRS (OR = 0.90, 95% CI [0.85, 
0.94]).
Diabetes was concurrently more likely to be seen 
with higher levels of neuroticism (OR = 1.03, 95% CI = 
[1.00, 1.06]) and lower levels of conscientiousness (OR 
= 0.85, 95% CI = [0.80, 0.91]). The diabetes-neuroticism 
relationship was only significant in the HRS (OR = 1.04, 
95% CI [1.00, 1.08]). The diabetes-conscientiousness link 
was significant in four studies: the ELSA (OR = 0.78, 95% 
CI [0.71, 0.85]), the HRS (OR = 0.78, 95% CI [0.75, 0.81]), 
the NAS (OR = 0.79, 95% CI [0.63, 0.99]), and the ROS (OR 
= 0.84, 95% CI [0.71, 0.99]).
Meta-analytically, conscientiousness was prospectively 
associated with the development of diabetes (OR = 0.88, 
95% CI = [0.84, 0.93]), but the meta-analytic relationship 
between neuroticism and later development of diabetes 
was nonsignificant (OR = 1.01, 95% CI = [0.97, 1.05]). 
The prospective diabetes-conscientiousness link was 
significant in four studies: the ELSA (OR = 0.74, 95% CI 
[0.64, 0.85]), the HRS (OR = 0.93, 95% CI [0.87, 0.98]), the 
MIDUS (OR = 0.85, 95% CI [0.77, 0.94]), and the WLS (OR 
= 0.89, 95% CI [0.83, 0.95]). The prospective diabetes-
neuroticism link was not significant in any of the studies.
Heart disease is concurrently more likely to be seen at 
lower levels of conscientiousness (OR = 0.88, 95% CI = [0.83, 
0.94]) and higher levels of neuroticism (OR = 1.08, 95% CI 
= [1.03, 1.12]). The heart disease-neuroticism relationship 
was significantly positive in the BASE-II (OR = 1.22, 95% CI 
[1.03, 1.45]), the HRS (OR = 1.06, 95% CI [1.03, 1.10]), and 
the WLS (OR = 1.15, 95% CI [1.06, 1.25]). Heart disease and 
conscientiousness were significantly negatively associated 
in many of the studies: the EAS (OR = 0.80, 95% CI [0.67, 
0.94]), the ELSA (OR = 0.77, 95% CI [0.73, 0.83]), the HRS 
(OR = 0.83, 95% CI [0.80, 0.85]), the ILSE (OR = 0.79, 95% CI 
[0.65, 0.96]), the MAS (OR = 0.84, 95% CI [0.73, 0.97]), the 
MIDUS (OR = 0.89, 95% CI [0.82, 0.97]) and the NAS (OR = 
0.72, 95% CI [0.60, 0.86]). Notably, conscientiousness was 
associated with greater rates of heart disease in the BASE-II 
(OR = 1.22, 95% CI [1.02, 1.46]).
Conscientiousness was prospectively associated with 
developing heart disease (b = –0.05, OR = 0.95, 95% 
CI = [0.92, 0.99], p = .014) but neuroticism was not 
(OR = 1.04, 95% CI = [0.99, 1.10]). The prospective 
neuroticism-heart disease link was significant for the 
BASE-II (OR = 1.35, 95% CI [1.08, 1.70]) and the HRS (OR 
= 1.08, 95% CI [1.03, 1.14]). The prospective relationship 
between conscientiousness and heart disease was only 
significant in the HRS (OR = 0.91, 95% CI [0.87, 0.96]). 
The full results for these main effects can be seen at osf.
io/7zmyg.
N × C Interactions and Concurrent Condition Status
Based on the weighted average effect size, 
conscientiousness did not significantly moderate the 
concurrent relationship of neuroticism to hypertension 
(OR = 1.00, 95% CI = [0.97, 1.02]), diabetes (OR = 1.01, 
95% CI = [0.99, 1.04]), or heart disease (OR = 0.99, 
95% CI = [0.97, 1.02]; see Figure 1 for the results of all 
cross-sectional meta-analyses). Additionally, Figure 2 
depicts the predicted likelihood of having each chronic 
condition by neuroticism score for each dataset, with 
separate predictions for high (+1SD) and low (-1SD) 
conscientiousness scores. This figure captures well the 
overall strength of the neuroticism-health relationship, as 
well as the heterogeneity in the hypertension models.
Heterogeneity between interaction effect sizes was not 
significant for the diabetes models (Q(014) = 13.35, p 
= .499, I2 = 0.02%) or the heart disease models (Q(013) 
= 11.19, p = .595, I2 = 0.00%). For the hypertension 
models, there was a significant amount of heterogeneity 
of interaction effect sizes between the studies (Q(014) = 
23.85, p = .048, I2 = 19.98%). Consequently, we assessed 
whether the use of one personality scale versus another 
may explain study level differences. We chose the NEO-
PI-R as a baseline measure for comparison against the 
other personality measurements. None of the scales – 
the MIDI (b = 0.01, 95% CI [–0.06, 0.08], the NEO-FFI (b 
= 0.04, 95% CI [–0.05, 0.13]), or the BFI (b = 0.07, 95% 
CI [0.00, 0.15]) – yielded results that were significantly 
different from this baseline measure.
Given the heterogeneity of results, we also examine 
the interaction of neuroticism and conscientiousness on 
the likelihood of having hypertension in the individual 
studies. This coefficient was significant for only two 
studies: BASE-II (OR = 1.19, 95% CI = [1.05, 1.35]) and EAS 
(95% CI = [0.72, 0.99]). Notably, the coefficients for these 
studies are in opposite directions, suggesting the shape 
of the interaction is different between them. For BASE-II, 
neuroticism was associated with greater likelihood of 
having hypertension when conscientiousness was high 
(e.g., when conscientiousness was one standard deviation 
above the mean, OR = 1.42, 95% CI = [1.20, 1.68]), but was 
not associated with hypertension when conscientiousness 
was low (e.g., when conscientiousness was one standard 
deviation below the mean, OR = 1.00, 95% CI = [0.82, 
1.22]). In the EAS, neuroticism was not associated with 
hypertension at low levels of conscientiousness (OR = 1.08, 
95% CI = [0.85, 1.38]), but high levels of conscientiousness 
combined with high levels of neuroticism tended to 
be associated with lower odds ratios for hypertension 
although the effect was not statistically significant (OR = 
0.78, 95% CI = [0.60, 1.00]).
N × C Interactions and Prospective Condition 
Development
Binary logistic regression models were fit within each 
study to estimate whether the interaction of neuroticism 
and conscientiousness was prospectively linked with the 
development of hypertension, diabetes or heart disease. 
For these analyses, we used the assessment of chronic 
condition at the last wave of data provided by each 
participant; a consequence is that time since baseline varies 
across participants as well as across datasets. Participants 
were excluded from these analyses if they had been 
diagnosed with the chronic condition at baseline or earlier. 
Based on the weighted average effect size, the interaction 
was not significantly associated with the development of 
hypertension (OR = 0.98, 95% CI = [0.95, 1.01]), diabetes 
(OR = 0.98, 95% CI = [0.93, 1.02]), or heart disease (OR 
= 0.98, 95% CI = [0.94, 1.03]). Moreover, only for one 
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outcome in one study was the interaction coefficient 
significant (when estimating incidence of heart disease in 
the ELSA, OR = 0.88, 95% CI = [0.80, 0.96]). See Figure 3 
for the interaction coefficient of each study, the weighted 
average affects and the simple slopes of neuroticism.
Exploratory analysis: N × C × age
After viewing the results of the coordinated analysis, it 
was suggested by some that there could be a three-way 
interaction of neuroticism by conscientiousness by age. 
Despite having not pre-registered these analyses, we do 
believe they could be informative, as both health and 
personality change systematically with age (e.g., Wagner, 
Ram, Smith, & Gerstorf, 2016; Chopik & Kitayama, 2018; 
Letzring, Edmonds, & Hampson, 2014). We chose to 
include these exploratory analyses, and we present the 
results without significance tests. Weighted interaction 
effects were small and confidence intervals contained an 
odds ratio of 1 (hypertension: OR = 0.99, 95% CI = [0.95, 
1.03]; diabetes: OR = 1.04, 95% CI = [0.97, 1.10]; heart 
Figure 1: Forest plots for cross-sectional analyses. Code to produce figure available at ialsaging.github.io/healthyN.
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disease: OR = 1.00, 95% CI = [0.95, 1.06]), indicating that 
the interaction of neuroticism and conscientiousness was 
not more strongly related to chronic condition status in 
older participants. This pattern was largely repeated in 
individual studies. Effect sizes were large and confidence 
intervals excluded 1 on three occasions: with hypertension 
in the OATS OR = 7.90, 95% CI = [1.10, 56.95]), with 
diabetes in the WLS OR = 1.11, 95% CI = [1.00, 1.22]), 
and with heart disease in the ILSE OR = 63.04, 95% CI 
= [1.28, 3104.32]). Given that (1) we did not preregister 
these analyses, (2) the number of statistical tests across 
all outcomes and all datasets is large, and (3) these 
confidence intervals either contain the null (OR = 1.00) 
or have very wide upper boundaries, we do not have faith 
in the validity of these “significant” results. Therefore, we 
interpret these findings as more likely noise rather than 
signal.
Discussion
Our coordinated analysis did not find consistent 
evidence that the relationship between neuroticism and 
the chronic conditions of hypertension, diabetes, and 
heart disease varies across levels of conscientiousness. 
These null associations contribute to a broader theory 
of healthy neuroticism (Friedman, 2000), which posits 
that neuroticism may be beneficial for some individuals 
or under some conditions. Specifically, the current study 
provides no evidence that high levels of neuroticism 
may be healthy for individuals who also have high levels 
of conscientiousness, nor does it find that the negative 
effects of neuroticism on health are buffered by high levels 
of conscientiousness. These null results counter previous 
findings that the neuroticism by conscientiousness 
interaction was associated with better health (Turiano 
et al., 2013, 2012; Vollrath & Torgersen, 2002; Weston & 
Jackson, 2015).
The current study is the second of three studies 
rigorously testing the healthy neuroticism hypothesis. 
The conclusions of the current study mirror that of the 
third study, which found that the relationship between 
neuroticism and mortality does not differ across levels 
of conscientiousness. However, the first study found 
that higher neuroticism was less strongly associated 
with greater rates of smoking and lower rates of 
physical activity at higher levels of conscientiousness. 
Together, the three studies in this coordinated project 
Figure 2: Predicted probabilities of concurrently having each chronic condition. Code to produce figure available at 
ialsaging.github.io/healthyN.
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suggest that while it may be true that so-called healthy 
neurotics engage in slightly better health behaviors, 
this effect is not substantial enough to impact overall 
health. This pattern of associations could be explained 
in several ways. For example, conscientiousness may 
curb the behavioral tendencies of individuals high in 
neuroticism but do little to reduce the physiological 
stress experienced by those high in trait anxiety 
(Barlow, 2000). Alternatively, interactions between 
these traits may only be associated with health for 
some populations, for example, already-ill samples 
(as suggested by Weston & Jackson, 2015) that are 
less likely to participate in longitudinal observational 
studies. Further, the effects on health behaviors may 
not be large enough to translate into actual differences 
in health outcomes.
Figure 3: Forest plots for longitudinal analyses. Code to produce figure available at ialsaging.github.io/healthyN.
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The current study (along with the others in this series) 
implies that personality and health researchers interested 
in the role of neuroticism should carefully reconsider 
the potential and limits for conscientiousness to act as 
a moderator. The current set of studies provides large 
and somewhat representative tests of this interaction 
and ultimately does not provide evidence for “healthy 
neuroticism”. Given these findings (and the likely large 
number of unpublished null results), we suspect this 
interaction cannot explain the discrepancies between 
mortality studies that first inspired the conception of 
healthy neuroticism (Friedman, 2000). Personality and 
health researchers may look to other individual differences, 
such as socioeconomic status (e.g., Hagger-Johnson et al., 
2012). We may also look to situations or contexts in which 
neuroticism may be beneficial, such as after someone has 
experienced a substantial health threat (Gale et al., 2017; 
Weston & Jackson, 2015). Consideration must also be 
given to recent large-scale examinations of neuroticism 
and mortality, which suggest that neuroticism may not be 
as strongly linked with health as it was previously believed 
to be (Graham et al., 2017; Jokela et al., 2013). In other 
words, perhaps we mistook error for heterogeneity. If the 
true relationship between neuroticism and health is null, 
then we should expect to find samples with “positive” 
effects of neuroticism and other samples with “negative” 
effects. Instead of searching for a moderator, the simpler 
explanation may be that no relationship exists.
Constraints on generality
The set of studies included in this coordinated analysis, 
while considerable in size, is not comprehensive. 
The included studies are largely WEIRD samples 
(i.e., Westernized, Educated, Industrialized, Rich, and 
Democratic; Henrich, Heine, & Norenzayan, 2010). Our 
results may not generalize to Eastern cultures or less-
industrialized countries. and disadvantaged populations 
within the cultures studied here. Results are also likely 
limited to the chronic conditions that we studied and 
may not generalize to cognitive (e.g., Alzheimer’s) or 
non-behavioral conditions (e.g., lymphoma). We believe 
these results would generalize to measures of personality 
that were not used in the present study. There was 
little evidence that the present scales yielded different 
conclusions from each other, and we have no reason to 
believe these scales vary in a systematic way from other 
scales. We also believe that these results are likely to 
generalize over time, as both the personality and health 
measurements varied across time within this project; that 
is, these results would be expected in samples collected in 
the past and also the foreseeable future.
The current study, along with the others in this series, 
estimated population-level relationships between 
constructs through the coordinated analysis approach. 
One benefit of coordinated analysis is the ability to 
compare methods of data collection or cohorts to 
find the boundary conditions of an effect (Hofer & 
Piccinin, 2010). However, we found limited evidence of 
heterogeneity of effects across data sets. The observed 
null effects of neuroticism and conscientiousness on 
health were replicated across studies in different cultures, 
with different measures of personality, and across 
different time spans. This underscores our conclusion 
that the relationship of neuroticism to concurrent and 
prospective health conditions is unrelated to levels of 
conscientiousness.
The current study was limited by the data available. 
Nearly all measures were self-reported. Ideally, future 
research will utilize medical diagnoses and physician 
reports of health or biological indicators of health. Finally, 
the current study used binary coding to harmonize 
measures of health status across studies. This choice was 
made to compare results across countries, time between 
assessments, and measures of personality; however, we 
are unable to distinguish between different severities of 
diagnosis within a condition (e.g., a heart murmur versus a 
heart attack, or Type I versus Type II diabetes). It is possible 
that healthy neuroticism may not explain differences in 
having a chronic condition, but rather in the severity of 
a chronic condition, and we would be unable to see this 
effect in the current analysis. Finally, the prospective 
analyses omitted participants who were diagnosed at 
baseline, with the explicit purpose of assessing incidence 
of chronic conditions. Selection effects may have biased 
the results if those who became diagnosed or those with 
specific personality profiles dropped out of the study in 
systematic ways.
Model generalizability is constrained by missing data in 
these models. For any longitudinal study, attrition causes 
bias in the results. Here, it may be the case that participants 
who become ill between waves may be missing, thus 
selecting out the most extremely ill cases. Additionally, 
certain personality characteristics (notably, agreeableness 
and openness; Salthouse, 2013) are associated with 
repeated participation in longitudinal studies, so we may 
lose participants low in these traits from the sample over 
time.
Conclusion
There is no substantial evidence that healthy neuroticism 
(as defined by conscientiousness-as-moderator) is 
associated with chronic condition status. The profile of 
high-neuroticism and high-conscientiousness may be 
associated with healthier behaviors, but this does not 
translate into better overall health, based on the chronic 
conditions considered here. If we continue to believe that 
neuroticism may, in some contexts or for some persons, 
be associated with better health, we should refrain from 
further testing conscientiousness as the determining 
factor in this relationship and devote our resources to 
other theoretical constructs.
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